KMS Medisurgi Limited Stock Price Today (NSE: KMSMEDI)

KMS Medisurgi Limited

132.80+0.00 (+0.00%)
Market Closed

Fundamental Score

...

KMS Medisurgi Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

KMS Medisurgi Limited share price today is 132.80, up +0.00% on NSE/BSE as of 23 June 2026. KMS Medisurgi Limited (KMSMEDI) is a Small-cap company in the Healthcare Equipment & Supplies sector with a market capitalisation of 41.75 (Cr). The 52-week high for KMSMEDI share price is 132.80 and the 52-week low is 120.50. At a P/E ratio of 94.89x, KMSMEDI is currently trading above its industry average P/E of 47.12x. The company has a Return on Equity (ROE) of 5.59% and a debt-to-equity ratio of 0.11.

KMS Medisurgi Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
132.80
Low
126.50
Volume
90.9090909090909
Change
+4.98%

KMS Medisurgi Limited share price chart: 4.98% return over the past month. 52-week high ₹132.80, 52-week low ₹120.50.

KMS Medisurgi Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)
132.80132.80132.80132.800.00 (Cr)

KMS Medisurgi Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
132.80132.80132.80132.80+0.00%
126.50132.80126.50132.80+4.98%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.50126.50+0.00%
126.50126.50126.45126.50+0.00%
120.50126.50120.50126.50+4.98%
126.90132.30120.50120.50-5.04%

Returns & Performance

Poor

Return on Equity (ROE)

5.59%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

8.26%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

6.69%

Average operating profit margin over 5 years

Dividend Yield

0.04%

Annual dividend as % of current share price

KMS Medisurgi Limited Valuation Check

Poor

Price to Earnings (P/E)

94.89x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

47.12x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

74.42%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

340.00%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-9.06%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

6.16%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

31.95%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

31.95%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.11x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

7.10x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

1.50 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

KMS Medisurgi Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KMSMEDI across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Robust Profit Growth (340.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Excellent EPS Growth (31.95% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (31.95% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.11)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (7.10x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (74.42%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Below-Average Return on Equity (5.59%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (8.26%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 94.89x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Revenue Contraction (-9.06%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

KMS Medisurgi Limited vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare KMS Medisurgi Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
43.5/100
133
₹41.75
94.9
Average
5.59%
Poor
8.26%
Poor
0.1
Excellent
31.95%
Excellent
6.16%
Good
0.04%
60.7/100
1330
₹19506.20
53.9
Average
15.77%
Good
20.08%
Excellent
0.1
Excellent
28.38%
Excellent
19.44%
Excellent
0.18%
31.7/100
37
₹3162.93
157.5
Average
0.70%
Poor
1.08%
Poor
0.1
Excellent
0.01%
68.7/100
243
₹1488.44
57.8
Average
21.88%
Excellent
19.20%
Good
0.0
Excellent
57.51%
Excellent
9.81%
Good
0.00%
42.1/100
497
₹1363.11
50.1
Average
30.08%
Excellent
31.14%
Excellent
0.6
Good
0.00%
13.8/100
215
₹1224.98
59.6
Average
4.75%
Poor
6.91%
Poor
0.6
Good
0.00%
60.3/100
173
₹633.93
25.8
Average
36.78%
Excellent
31.12%
Excellent
0.5
Good
90.06%
Excellent
61.82%
Excellent
0.00%
68.5/100
408
₹521.17
26.2
Average
18.74%
Good
25.25%
Excellent
0.0
Excellent
29.49%
Excellent
22.80%
Excellent
0.23%
61.2/100
413
₹354.57
34.2
Average
13.58%
Average
16.35%
Good
0.4
Excellent
74.11%
Excellent
13.69%
Good
0.00%
47.7/100
187
₹294.37
32.7
Average
13.56%
Average
18.45%
Good
0.0
Excellent
0.00%
Nureca Ltd...
NURECA543264
36/100
272
₹292.61
71.2
Average
-1.12%
Poor
-0.90%
Poor
0.0
Excellent
1.98%
Average
0.00%

KMS Medisurgi Limited Quarterly Performance

Latest quarterly metrics for KMSMEDI — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-9.06%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

340.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

6.16%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

31.95%

Compounded annual net profit growth over 5 years

KMS Medisurgi Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KMSMEDI — calculated from daily price history

100RSI 14
Overbought — RSI 100

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
128
▲ Price above SMA 50 — Short-term bullish
SMA 200
127
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
0K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

KMS Medisurgi Limited Financial Statements

Annual income statement, balance sheet and cash flow for KMS Medisurgi Limited (KMSMEDI) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for KMS Medisurgi Limited

About KMSMEDI (KMS Medisurgi Limited)

KMS Medisurgi Limited is a dynamic global manufacturer and distributor specializing in medical equipment and supplies. The company has carved a niche for itself in the internationa...l healthcare market by focusing on high-quality surgical equipment and advanced wound care solutions. It expertly combines innovation with practicality, resulting in a diverse product line designed to meet the rigorous demands of modern medical practices. KMS Medisurgi prides itself on its commitment to stringent quality control and adherence to global regulatory standards, ensuring that its products are reliable and effective across a broad spectrum of clinical applications. KMS Medisurgi's products are meticulously engineered to improve patient outcomes and enhance the efficiency of healthcare professionals. KMS Medisurgi's core strength lies in its comprehensive range of surgical and wound care products. These offerings encompass a wide variety of specialized tapes, including breathable microporous, gentle paper, crystal-clear transparent, cushioning gel, delicate silicone, classic silk, and protective foam options. Moreover, the company also provides adhesive tapes compliant with U.S. Pharmacopeia (USP) standards and non-woven surgical tapes with acrylic adhesive. This extensive portfolio demonstrates KMS Medisurgi's dedication to providing healthcare providers with the best tools for surgery and wound care, all designed with patient comfort and optimal healing in mind. These products are developed with careful consideration for the diverse needs of patients and clinicians, solidifying the company’s position as a leader in the field. KMS Medisurgi extends its reach across a vast international network, supplying its products to healthcare providers in key markets around the globe. Its products are present in diverse locations such as India, Dubai, Vietnam, Australia, Cambodia, Africa, the Philippines, Russia, Pakistan, Europe, Bangladesh, and the United States, the company is committed to providing a reliable supply of high-quality medical equipment and supplies to medical professionals worldwide. KMS Medisurgi remains focused on expanding its global presence through strategic partnerships and continued innovation, always striving to improve healthcare outcomes and enhance the quality of patient care.

Company Details

Symbol:KMSMEDI
Industry:Healthcare Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Siddharth Gaurang Kanakia
Chairman & MD
Mr. Anand Prataprai Kanakia
Chief Financial Officer
Ms. Pooja Soni
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

KMSMEDI Share Price: Frequently Asked Questions

What is the current share price of KMS Medisurgi Limited?

KMS Medisurgi Limited (KMSMEDI) trades at ₹132.80 on NSE and BSE. Market cap ₹41.75 (Cr). Educational data only.

What is the P/E ratio of KMS Medisurgi Limited?

KMS Medisurgi Limited has a P/E of 94.89x vs industry average 47.12x.

What is the Bull Run score for KMS Medisurgi Limited?

KMS Medisurgi Limited has a Bull Run score of 43.5/100 based on 25+ financial parameters.

Does KMS Medisurgi Limited pay dividends?

KMS Medisurgi Limited has a dividend yield of 0.04%. Past dividends don't guarantee future payments.

What is the ROE of KMS Medisurgi Limited?

KMS Medisurgi Limited has ROE of 5.59%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of KMS Medisurgi Limited?

KMS Medisurgi Limited has debt-to-equity of 0.11.

Is KMS Medisurgi Limited a good investment?

Bull Run gives KMS Medisurgi Limited a score of 43.5/100. This is not investment advice — consult a SEBI-registered advisor.